Urology
Volume 74, Issue 1 , Pages 22-27 , July 2009

Bone Disease in Patients With Primary Hypercalciuria and Calcium Nephrolithiasis

Received 10 March 2008 ,Accepted 4 November 2008.

References 

  1. Hodgkinson A, Pyrah LN. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg. 1958;46:10–18
  2. Smith LH, VanDenBerg CJ, Wilson DM. Nutrition and urolithiasis. N Engl J Med. 1980;98:87–89
  3. Pak CY. Medical management of nephrolithiasis. J Urol. 1982;128:1157–1164
  4. Pak CY, Ohata M, Lawrence EC, et al. The hypercalciurias: causes, parathyroid functions, and diagnostic criteria. J Clin Invest. 1974;54:387–400
  5. Heaney RP, Recker RR, Ryan RA. Urinary calcium in perimenopausal women: normative values. Osteoporos Int. 1999;9:13–18
  6. Kerstetter JE, O'Brian KO, Insogna KL. Low protein intake: the impact on calcium and bone homeostasis in humans. J Nutr. 2003;133:855S–861S
  7. Nordin BE, Need AG, Morris HA, et al. The nature and significance of the relationship between urinary sodium and urinary calcium in women. J Nutr. 1993;123:1615–1622
  8. Hegsted M, Schuette SA, Zemel MB, et al. Urinary calcium and calcium balance in young men as affected by level of protein and phosphorus intake. J Nutr. 1981;111:553–562
  9. Zemel MB. Calcium utilization: effect of varying level and source of dietary protein. Am J Clin Nutr. 1988;48:880–883
  10. Kerstetter JE, O'Brien KO, Insogna KL. Dietary protein, calcium metabolism, and skeletal homeostasis revisited. Am J Clin Nutr. 2003;78:584S–592S
  11. Albright F, Henneman P, Benedict PH, et al. Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med. 1953;46:1077–1081
  12. Pak CY, Britton F, Peterson R, et al. Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria. Am J Med. 1980;69:19–30
  13. Vezzoli G, Tanini A, Ferrucci L, et al. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol. 2002;13:2517–2523
  14. Broadus AE, Insogna KL, Lang R, et al. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med. 1984;311:73–80
  15. Li XQ, Tembe V, Horwitz GM, et al. Increased intestinal vitamin D receptor in genetic hypercalciuric rats: a cause of intestinal calcium hyperabsorption. J Clin Invest. 1993;91:661–667
  16. Zerwekh JE, Reed BY, Heller HJ, et al. Normal vitamin D receptor concentration and responsiveness to 1,25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab. 1998;24:307–313
  17. Prié D, Ravery V, Boccon-Gibod L, et al. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int. 2001;60:272–276
  18. Bushinsky DA. Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens. 1999;8:479–488
  19. Bataille P, Fardellone P, Ghazali A, et al. Pathophysiology and treatment of idiopathic hypercalciuria. Curr Opin Rheumatol. 1998;10:373–388
  20. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med. 1998;98:50–59
  21. Weisinger JR. New insights in the pathogenesis of idiopathic hypercalciuria: the role of bone. Kidney Int. 1996;49:1507–1518
  22. Lawoyin S, Sismilich S, Browne R, et al. Bone mineral content in patients with calcium urolithiasis. Metabolism. 1979;28:1250–1254
  23. Fuss M, Gillet C, Simon J, et al. Mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol. 1983;9:32–34
  24. Pacifici R, Rothstein M, Rifas L, et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab. 1990;71:138–145
  25. Bataille P, Achard JM, Fournier A, et al. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int. 1991;39:1193–1205
  26. Borghi L, Meschi T, Guerra A, et al. Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol. 1991;146:1334–1338
  27. Pietschmann F, Breslau NA, Pak CY. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res. 1992;12:1383–1388
  28. Jaeger P, Lippuner K, Casez JP, et al. Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res. 1994;10:1525–1532
  29. Weisinger JR, Alonzo E, Bellorin-Font E, et al. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int. 1996;49:244–250
  30. Ghazali A, Fuentes V, Desaint C, et al. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab. 1997;82:32–38
  31. Giannini S, Nobile M, Sartori L, et al. Density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol. 1998;50:94–100
  32. Misael da Silva AM, dos Reis LM, Pereira RC, et al. Involvement in idiopathic hypercalciuria. Clin Nephrol. 2002;57:183–191
  33. Tasca A, Cacciola A, Ferrarese P, et al. Alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urology. 2002;59:865–869
  34. Asplin JR, Bauer KA, Kinder J, et al. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003;63:662–669
  35. Vezzoli G, Rubinacci A, Bianchin C, et al. Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria. Am J Kidney Dis. 2003;42:1177–1183
  36. Caudarella R, Vescini F, Buffa AB. Mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol. 2003;16:260–266
  37. Barkin J, Wilson DR, Manuel MA, et al. Mineral content in idiopathic calcium nephrolithiasis. Miner Electrolyte Metab. 1985;11:19–24
  38. Satton RAL, Walker VR. Bone resorption and hypercalciuria in calcium stone formers. Metabolism. 1986;35:485–488
  39. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21:115–137
  40. Gowen M, Mundy GR. Actions of recombinant interleukin 1, interleukin 2 and interferon gamma on bone resorption in vitro. J Immunol. 1986;136:2478–2482
  41. Giannini S, Nobile M, Sartori L, et al. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr. 1999;9:267–271
  42. Maierhofer WJ, Gray RW, Cheung HS, et al. Bone resorption stimulated by elevated serum 1 and 25 (OH)2-vitamin D concentrations in healthy men. Kidney Int. 1983;24:555–560
  43. Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol. 2003;14:1082–1095
  44. Fuss M, Pepersack T, Bergman P, et al. Low calcium diet in idiopathic urolithiasis: a risk factor for osteopenia as great as in primary hyperparathyroidism. Br J Urol. 1990;65:560–563
  45. Hess B. Low calcium diet in hypercalciuric calcium nephrolithiasis: first do not harm. Scan Microsc. 1996;10:547–554
  46. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–838
  47. Heilberg IP, Martini LA, Szejnfeld VL. Bone disease in calcium stone forming patients. Clin Nephrol. 1994;42:175–182
  48. Bordier P, Rychewart A, Gueris J, et al. On the pathogenesis of so-called idiopathic hypercalciuria. Am J Med. 1977;63:398–409
  49. Steiniche T, Mosekilde L, Christensen MS, et al. A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. Acta Pathol Microbiol Immunol Scand. 1989;97:309–316
  50. Malluche HH, Tschoepe W, Ritz E, et al. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab. 1980;50:654–658
  51. Zerwekh JE, Sakhaee K, Breslau NA, et al. Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int. 1992;2:128–134
  52. Prié D, Huart V, Bakouh N, et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium phosphate cotransporter. N Engl J Med. 2002;347:983–991

PII: S0090-4295(08)01894-3

doi: 10.1016/j.urology.2008.11.014

Urology
Volume 74, Issue 1 , Pages 22-27 , July 2009

Article Tools

* Image Usage & Resolution